Annette Bakker's guest appearances

Annette Bakker

De Zzzzzondag! Podcast

In House Warrior

Tom Campbell

Donald Trump

Bill Clinton

Mark Goulston

Michael Parker

Michael Caputo

Tom White

Mark Babbitt

Jeffrey Smith

Larry Nassar

Paul Smith

Michael Levin

Ty Cobb

Suzanne Kelly

Tim Brown

OwlTail

Richard Levick

Cures For Many Rare Diseases May Already Exist: In a “call for the courageous” Annette Bakker, a PhD in Biochemistry and President of the Children’s Tumor Foundation, speaks with host Richard Levick of LEVICK about the fact that cures for cystic fibrosis, muscular dystrophy, neurofibromatosis and rare cancers may have already been developed but that scientists don’t realize it yet. With minor tweaks, some of pharma's discarded drugs could be turned into game-changing therapies for currently untreatable diseases. Big Pharma will need big business incentives -- whether that’s the promise of higher ESG scores, new investors or a stake in the repurposed drugs -- to agree so CTF developed the BRIDGE initiative to helps find just such incentives. CTF has built worldwide collaborative science networks, an open biobank, a centralized data collection and integration platform, a patient registry and more to make it easier and more economically viable for pharmaceutical companies to recycle old drugs to save lives. CTF has already successfully worked with one major drug company to repurpose a discontinued medicine that may end up helping treat a number of rare tumors.

<p>Cures For Many Rare Diseases May Already Exist: In a “call for the courageous” Annette Bakker, a PhD in Biochemistry and President of the <a href="https://www.ctf.org/" rel="nofollow" target="_blank">Children’s Tumor Foundation</a>, speaks with host Richard Levick of LEVICK about the fact that cures for cystic fibrosis, muscular dystrophy, neurofibromatosis and rare cancers may have already been developed but that scientists don’t realize it yet. With minor tweaks, some of pharma's discarded drugs could be turned into game-changing therapies for currently untreatable diseases. Big Pharma will need big business incentives -- whether that’s the promise of higher ESG scores, new investors or a stake in the repurposed drugs -- to agree so CTF developed the BRIDGE initiative to helps find just such incentives. CTF has built worldwide collaborative science networks, an open biobank, a centralized data collection and integration platform, a patient registry and more to make it easier and more economically viable for pharmaceutical companies to recycle old drugs to save lives. CTF has already successfully worked with one major drug company to repurpose a discontinued medicine that may end up helping treat a number of rare tumors.</p>

Cures For Many Rare Diseases May Already Exist with Annette Bakker, a PhD in Biochemistry and President of the Children's Tumor Foundation and Richard Levick of LEVICK

De talkshow van Stadsschouwburg Utrecht, met hosts Patrick Nederkoorn &amp; Oscar Kocken. Op 2 mei ontvingen ze Annette Bakker, stadsarcheoloog van Utrecht. "De politie wordt eerst geroepen om te bekijken of het geen misdrijf is. Wij komen dan ook om te zeggen: nee het is ouder dan 50 jaar." Tot ziens in Stadsschouwburg Utrecht!

<p>De talkshow van Stadsschouwburg Utrecht, met hosts Patrick Nederkoorn &amp; Oscar Kocken. Op 2 mei ontvingen ze Annette Bakker, stadsarcheoloog van Utrecht. "De politie wordt eerst geroepen om te bekijken of het geen misdrijf is. Wij komen dan ook om te zeggen: nee het is ouder dan 50 jaar." Tot ziens in Stadsschouwburg Utrecht!</p>

Zzzzzondag! met Annette Bakker